ASX CODE: THC
THC Global obtains licence for Australia’s largest medicinal cannabis facility
Australian medicinal cannabis developer THC Global (ASX: THC) has been granted a second manufacturing licence, this time for its large Southport facility, making it...
THC Global and Eve Investments to advance medicinal cannabis partnership following manufacturing licence
In the wake of THC Global (ASX: THC) reporting it has secured its medicinal cannabis manufacturing licence, partner Eve Investments (ASX: EVE) noted the...
THC’s Canndeo gets green light to manufacture medicinal cannabis extracts
THC Global's (ASX: THC) wholly-owned subsidiary Canndeo has achieved a major milestone by securing a manufacturing licence to produce cannabis extracts and tinctures in...
THC Global enters Canadian market with land acquisition for new cannabis production facility
Australian-based medicinal cannabis developer THC Global (ASX: THC) is set to become a licenced cultivator following the acquisition of a 16,000 square metre site...
The Hydroponics Company bulks up balance sheet with $16.7 million revaluation
Medicinal cannabis developer The Hydroponics Company (ASX: THC) has updated its shareholders with the news that it had revalued its Southport pharmaceutical manufacturing facility by $14.58 million,...
Hydroponics Company beds into blossoming Canadian cannabis market
The influence of Australian companies grabbing a foothold in Canada’s blossoming cannabis market continues to grow as The Hydroponics Company (ASX: THC) has concluded a...
The Hydroponics Company lines up route to cannabis market
Medicinal cannabis developer The Hydroponics Company (ASX: THC) has provided an interim update to the market regarding its rapid progress towards becoming a fully-fledged medical...
The Hydroponics Company looks to seize tea tree extract commercial opportunity
Medicinal cannabis developer The Hydroponics Company (ASX: THC) is aiming to add significant production capabilities to its recently-acquired growing facility, and thereby continue the build-up of...
The Hydroponics Company flying high with newly-acquired facility and substantial revenue growth
Burgeoning medical cannabis producer The Hydroponics Company (ASX: THC) is back trading on the ASX after coming out of its trading halt imposed last...
The Hydroponics Company gets import approval, provides medicinal cannabis product for Tourette’s Syndrome clinical...
The Hydroponics Company (ASX: THC) has been given the green light to import medicinal cannabis products from its European partner Endoca after locking in...
The Hydroponics Company gets high on another supply deal, this time with BOL Pharma
Less than a week after signing an agreement with European supplier Endoca, The Hydroponics Company (ASX: THC) reported it has teamed up with Israeli...
The Hydroponics Company secures Australian distribution agreement with Endoca
The Hydroponics Company (ASX: THC) announced its subsidiary Canndeo Ltd has secured an agreement with Europe-based Endoca to distribute cannabis throughout Australia.
Endoca produces GMP...
The Hydroponics Company secures medicinal cannabis licence
The Hydroponics Company (ASX: THC) has clinched its medicinal cannabis licence, leaving only its manufacturing licence left to be granted before it can legally...
The Hydroponics Company increases first quarter revenue to over $1.1m
The Hydroponics Company Limited (ASX: THC) has announced that first quarter revenue in its wholly owned subsidiary Crystal Mountain/Dragon Vision increased by more than...
